Peripheral effects of methionine-enkephalin on inflammatory reactions and behavior in the rat

NeuroImmunoModulation

Volumn 8, Issue 2, 2000, Pages 70-77

  Vujić Redžić, Vesna ^b   Dimitrijević, Mirjana ^a,d   Stanojević, Stanislava ^a   Kovačević Jovanović, Vesna ^a   Miletić, Tatjana ^a   Radulović, Jelena ^c  

^a Immunology Research Center 'Branislav Jankovic'   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d Immunology Research Center Belgrade   (Yugoslavia)

Author keywords

Anti methionine enkephalin antibodies; Behavior; H2O2 release; Methionine enkephalin; Paw edema; Peritoneal macrophages; Rat

Indexed keywords

ANTIBODY; CONCANAVALIN A; HYDROGEN PEROXIDE; METENKEPHALIN; NALTREXONE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNITY; IMMUNOMODULATION; IMMUNOPOTENTIATION; INFLAMMATION; LOCOMOTION; MALE; NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; PAW EDEMA; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; WRITHING TEST;

EID: 0033803297     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026455     Document Type: Article

References (49)

1. Janković BD, Marić D: Enkephalins and autoimmunity: Differential effects of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats. J Neurosci Res 1988;18:88-94.
2. Janković BD, Radulović J: Enkephalins, brain and immunity: Modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 1992; 67:241-270.
3. Radulović J, Mančev Z, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Pešić G: Modulation of humoral immune response by central administration of leucine-enkephalin: Effects of μ, δ and κ opioid receptor antagonists. J Neuroimmunol 1996;65:155-161.
4. Adamson WT, Windh RT, Blackford S, Kuhn CM: Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis. Endocrinology 1991; 129: 959-964.
5. Carr DJ, Gebhardt BM, Paul D: Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 1993;264:1179-1186.
6. Fecho F, Dykstra LA, Lysle DT: Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 1993;265:1079-1087.
7. Lopker A, Abood LG, Hoss W, Lionetti FJ: Stereoselective muscarinic, acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem Pharmacol 1980;29:1361-1365.
8. Ansiello CM, Roda, LG: Leu-enkephalin binding to cultured human T-lymphocytes. Cell Biol Int Rep 1984;8:353-362.
9. Mathews PM, Froelich JC, Sibbit LW, Bankhurst DA: Enhancement of nature cytotoxicity by β-endorphin. J Immunol 1983;130:1658-1662.
10. Carr DJ, DeCosta BR, Kim C-H, Jacobson AE: Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes. J Endocrinol 1989;122:161-168.
11. Radulescu RT, DeCosta BR, Jacobson AE, Rice KC, Blalock JE, Carr DJ: Biochemical and functional characterization of a μ-opioid receptor binding site on cells of the immune system. PNEI 1991;4:166-179.
12. Gavériaux C, Peluso J, Simonin F, Laforet J, Kieffer B: Identification of κ- and δ-opioid transcripts in immune cells. FEBS Lett 1995; 369:272-276.
13. Hsueh C-M, Hiramoto RN, Ghanta VK: The central effect of methionine-enkephalin on NK cell activity. Brain Res 1992;578:142-148.
14. Janković BD, Marić D: Enkephalins as regulators of inflammatory immune reactions; in Sharrer M, Smith ME, Stefano GB (eds): Neuropeptides and Immunoregulation. Berlin, Springer, 1994, pp 76-100.
15. Janković BD, Marić D: Enkephalins modulate in vivo immune reactions through delta- and mu-opioid receptors. Ann NY Acad Sci 1988; 540:691-693.
16. Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J: Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via δ-opioid receptors. Brain Behav Immun 1989;3:183-189.
17. Casellas AM, Guardiola H, Renaud FL: Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 1991;18:35-40.
18. Fischer EG, Falke NE: Endogenous opioid peptides stimulate human phagocytes: Functional and binding studies. Adv Biosci 1987;66:373-379.
19. Foris G, Medgyesi GA, Gyimesi E, Hauck M: Met-enkephalin induced alterations of macrophage functions. Mol Immunol 1984;21:747-750.
20. Radulović J, Dimitrijević M, Laban O, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Marković BM: Effect of met-enkephalin and opioid antagonists on rat macrophages. Peptides 1995;16:1209-1213.
21. Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE: Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br J Pharmacol 1984;83:271-279.
22. Radulović J, Miljević Č, Djergović D, Vujić V, Antić J, von Hörsten S, Janković BD: Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of κ opioid receptors. J Neuroimmunol 1995;57:55-57.
23. Churchill L, Roques BP, Kalivas PW: Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both μ and δ opioid receptors. Psychopharmacology 1995;120:347-355.
24. Leventhal L, Cole JL, Bodnar RJ: Reductions in locomotor activity following central opioid receptor subtype antagonists in rats. Physiol Behav 1996;60:833-836.
25. Beluzzi JD, Gran N, Garasky V, Sarantakis D, Wise CD, Sein L: Analgesia induced in vivo by central administration of enkephalin in rat. Nature 1976;260:625-626.
26. Dauge V, Samir A, Cupo A, Roques BP: Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the partial derivative opioid system in the nucleus accumbens of rat. Neuropharmacology 1999;38:999-1007.
27. Radulović J, Vujić V, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Radulović M: Naturally occurring anti-peptide antibodies in the rat: Anti-Met-Enk antibodies; in Lukić ML, Čolić M, Mostarica-Stojković M, Čuperlović K (eds): Immunoregulation in Health and Disease. London, Academic Press, 1997, pp 197-203.
28. Pick E, Mizel D: Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol 1981;46:211-226.
29. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
30. Whittle BA: The use of changes in capillary permeability in mice to distinguish between narcotic analgesics. Br J Pharmacol 1964;22:246-253.
31. Janković BD, Marić D: Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Ann NY Acad Sci 1987;496:115-125.
32. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A: Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990;87:5935-5939.
33. Schiable HG, Grubb BD: Afferent and spinal mechanisms of joint pain. Pain 1993;55:5-54.
34. Blalock JE, Smith EM: Human leukocyte interferon: Structural and biological relatedness to adrenocorticotropin hormone and endorphins. Proc Natl Acad Sci USA 1980;77:5972-5974.
35. Schäfer M, Carter L, Stein C: Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91:4219-4223.
36. Van Epps DE, Saland L: β-Endorphin and metenkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 1984;132:3046-3053.
37. Kowalski J: Augmenting effect of opioids on nitrite production by stimulated murine macrophages. Neuropeptides 1998;32:287-291.
38. + T cells. J Immunol 1996;157:5324-5328.
39. House RV, Thomas PT, Bhargava HN: A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 1996;17: 75-81.
40. Vujić V, Pešić G, Radulović J, Janković BD: Central modulation of humoral and cell mediated immune responses in the rat by endogenous enkephalin. Iugoslav Physiol Pharmacol Acta 1995;31:285-293.
41. Hagi K, Uno K, Inaba K, Muramatsu S: Augmenting effects of opioid peptides on murine macrophage activation. J Neuroimmunol 1994;50:71-76.
42. Roscetti G, Possenti R, Bassano E, Roda LG: Mechanisms of leu-enkephalin hydrolysis in human blood. Life Sci 1984;45:193-197.
43. Pardrige WM, Mietus LJ: Enkephalin and blood brain barrier: studies of binding and degradation in isolated microvessels. Endocrinology 1981;109:1138-1145.
44. Planas ME, Rodriguez L, Sanchez S, Pol O, Puig MM: Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 1995;60:67-71.
45. Michael-Titus A, Dourmap N, Costentin J, Schwartz JC: Role of delta-opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides 1990;15:89-100.
46. Browne RG, Segal DS: Behavioral effects of opiates and opioid peptides. Biol Psychiatr 1980;15:77-86.
47. Schulteis G, Martinez JL: Peripheral modulation of learning and memory: enkephalins as a model system. Psychopharmacology 1992;109: 347-364.
48. Klitenick MA, Wirtschafter D: Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area. J Pharmacol Exp Ther 1995;273:327-336.
49. Pešić S, Pešić G, Mančev Z, Malobabić Z: Effect of met-enkephalin on rat visceral pain. Acta Med Mediane 1996;2:5-11.